Sarita Mishra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sarita Mishra has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Bano Subia
Department of Biotechnology, Indian Institute of Technology Kharagpur, Kharagpur 721302, India
2 shared publications - Ujjwal Ranjan Dahiya
CSIR-Institute of Genomics and Integrative Biology, New Delhi 110021, India
2 shared publications - David Caballero
B’s Research Group, I3Bs – Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine
1 shared publication - Guilhem Velve Casquillas
Elvesys Microfluidics Innovation Centre, Paris 75011, France.
1 shared publication - Jessica Ayache
Elvesys Microfluidics Innovation Centre, Paris 75011, France.
1 shared publication - Rui Luis Reis
University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine
1 shared publication
Latest Publications
- Open Access
- 1 March 2021
- Published by Elsevier in Journal of Controlled Release
- Vol. 331, 103-120
Breast tumor-on-chip models: From disease modeling to personalized drug screening
- 1 March 2021
- Published by Elsevier in Journal of Controlled Release
- Vol. 331, 103-120
Open AccessBreast tumor-on-chip models: From disease modeling to personalized drug screening
- Open Access
- 22 May 2019
- Published by IntechOpen
Application of Bone Substitutes and Its Future Prospective in Regenerative Medicine
Bone is a hard and dense connective tissue that supports and maintains the body structure and functions. Several factors like aging, drugs, hormonal changes, and physical activities lead to several kinds of bone injuries/fracture. To address these problems, autologous bone graft is considered an ideal material. However, limited availability and complications related to its harvesting process like donor site morbidity and pain limit the use of autologous bone graft in bone regeneration. With increasing advances in technology, several bone substitute materials such as synthetics, bioceramics, and polymers are emerging as a substitute of auto- or allogenous bone for the treatment of bone defect. These bone substitute materials should be biocompatible, bioresorbable, osteoconductive, osteoinductive, and support the ingrowth of new bone. In this chapter, we summarize the currently available bone graft and bone substitute materials including biological and bio-inorganic factors. An overview of the associated advantages, challenges, and future perspectives to clinical implication is also discussed.
- 22 May 2019
- Published by IntechOpen
Open AccessApplication of Bone Substitutes and Its Future Prospective in Regenerative Medicine
Bone is a hard and dense connective tissue that supports and maintains the body structure and functions. Several factors like aging, drugs, hormonal changes, and physical activities lead to several kinds of bone injuries/fracture. To address these problems, autologous bone graft is considered an ideal material. However, limited availability and complications related to its harvesting process like donor site morbidity and pain limit the use of autologous bone graft in bone regeneration. With increasing advances in technology, several bone substitute materials such as synthetics, bioceramics, and polymers are emerging as a substitute of auto- or allogenous bone for the treatment of bone defect. These bone substitute materials should be biocompatible, bioresorbable, osteoconductive, osteoinductive, and support the ingrowth of new bone. In this chapter, we summarize the currently available bone graft and bone substitute materials including biological and bio-inorganic factors. An overview of the associated advantages, challenges, and future perspectives to clinical implication is also discussed.